Legal Representation
Attorney
Richard M. LaBarge
USPTO Deadlines
Next Deadline
94 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2005-10-18)
Due Date
October 18, 2025
Grace Period Ends
April 18, 2026
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 18, 2024 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Oct 21, 2015 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Oct 21, 2015 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Oct 21, 2015 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Oct 16, 2015 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Nov 16, 2011 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Nov 16, 2011 | C15P | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Nov 16, 2011 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Oct 17, 2011 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | Loading... |
| Oct 17, 2011 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Oct 7, 2011 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 7, 2011 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 18, 2005 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 6, 2005 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Sep 2, 2005 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 26, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Aug 26, 2005 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 17, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 17, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 1, 2005 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Jul 1, 2005 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Jun 29, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jun 15, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 15, 2005 | I | PAPER RECEIVED | Loading... | |
| Apr 18, 2005 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Apr 18, 2005 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Mar 15, 2005 | I | PAPER RECEIVED | Loading... | |
| Mar 11, 2005 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 11, 2005 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 14, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 10, 2004 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Jun 10, 2004 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Jun 10, 2004 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Sep 12, 2003 | I | PAPER RECEIVED | Loading... | |
| Sep 6, 2003 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Apr 1, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 12, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 28, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 16, 2003 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Nov 26, 2002 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Nov 19, 2002 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Aug 20, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 2, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 1, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 25, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 24, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; [ pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases;] assays, screening kits, devices, and equipment for medical analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; [ fungal lytic enzymes for the treatment of fungal infections;] pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders;[ proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions;] biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions
First Use Anywhere:
Jan 31, 2005
First Use in Commerce:
Jan 31, 2005
Classification
International Classes
005